Portfolio company
Okapi Sciences
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops antiviral drugs for veterinary applications to treat viral infections in pets and livestock.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
ViroVet
This company develops vaccines and antiviral drugs for livestock to control respiratory diseases and other viral infections in cattle, swine, sheep and goats.
Astra Therapeutics
The company develops novel anti-parasitic drugs to treat infections in pets and livestock.
The Vaccine Group
The company develops recombinant viral-vector vaccines and biotherapeutics for livestock and companion animals to control infectious and chronic diseases.
Resilient Biotics
This company develops microbiome-derived live biotherapeutics to prevent and treat respiratory diseases in livestock and humans.
Animol Discovery
This biopharmaceutical company develops small molecule medicines for companion and production animals using artificial intelligence and DNA-encoded library technologies.
ScoutBio
The company develops monoclonal antibodies and gene therapies for pets to treat chronic diseases.
Gallant Therapeutics
This company develops mesenchymal stromal cell therapies for veterinary professionals to treat inflammatory diseases and promote tissue repair in cats and dogs.
Biotangents
The company develops rapid molecular diagnostic tests for infectious diseases in livestock to assist veterinarians and farmers with point-of-care animal health management.